platinum has been researched along with Carcinoma, Small Cell in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, S; Hata, A; Komatsu, M; Ninomaru, T | 1 |
| Jiang, A; Lin, A; Luo, P; Mou, W; Zhang, J; Zhu, L | 1 |
| Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
| Fujisawa, M; Jimbo, N; Kimbara, S; Minami, H; Nakano, Y; Suzuki, K; Terakawa, T; Toyoda, M | 1 |
| Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH | 1 |
| Greco, FA | 1 |
| Duarte, RL; Luiz, RR; Paschoal, ME | 1 |
| Turrisi, AT | 1 |
| Cordier, JF; Trillet-Lenoir, V | 1 |
| Hirose, N; Nagashima, A; Nakahashi, H; Shimokawa, T; Yasumoto, K | 1 |
| Bauer, J; Fokkema, E; Groen, HJ; Smith, IE; Uges, DR; Weil, C | 1 |
| Zhang, M | 1 |
| Brann, TW; Frei, E; Herman, TS; Holden, SA; Khandekar, V; Korbut, TT; Rosbe, KW; Sotomayor, EA; Teicher, BA | 1 |
| Eguchi, K; Ohe, Y; Ohmori, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| de Vries, EG; Hospers, GA; Mulder, NH | 1 |
| de Leij, L; de Vries, EG; Hospers, GA; Meijer, C; Mulder, NH; Uges, DR | 1 |
| de Vries, EG; Hospers, GA; Martini, IA; Meijer, C; Mulder, NH; Muskiet, FA; Timmer-Bosscha, H; Uges, DR | 1 |
| Roed, H; Vindeløv, LL | 1 |
| Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
3 review(s) available for platinum and Carcinoma, Small Cell
| Article | Year |
|---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
[Origin of small cell lung cancers].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Neoplasm Metastasis; Platinum; Podophyllotoxin | 1993 |
Can human small-cell lung cancer cell lines be applied for optimizing chemotherapy?
Topics: Animals; Carcinoma, Small Cell; Colony-Forming Units Assay; DNA, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitrosourea Compounds; Platinum; Podophyllotoxin; Tumor Cells, Cultured | 1989 |
2 trial(s) available for platinum and Carcinoma, Small Cell
| Article | Year |
|---|---|
Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Platinum; Treatment Outcome | 1999 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
14 other study(ies) available for platinum and Carcinoma, Small Cell
| Article | Year |
|---|---|
Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case report.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Small Cell; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Humans; Lung Neoplasms; Mutation; Platinum; Protein Kinase Inhibitors; Small Cell Lung Carcinoma | 2022 |
Activation of the TGF-
Topics: Carcinoma, Small Cell; Humans; Lung Neoplasms; Platinum; Prognosis; Small Cell Lung Carcinoma | 2022 |
Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports.
Topics: Aged; Anthracyclines; Antineoplastic Agents; Carcinoma, Small Cell; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Platinum; Prognosis; Prostatic Neoplasms | 2020 |
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms | 2010 |
Topotecan as first-line therapy for small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Forecasting; Humans; Lung Neoplasms; Paclitaxel; Platinum; Topotecan | 2003 |
The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Risk Factors; Smoking; Treatment Outcome | 2008 |
Considerations on radiotherapy dose intensity for limited small cell lung cancer.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Lung Neoplasms; Platinum; Radiotherapy Dosage; Time Factors | 1994 |
Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Instillation, Drug; Lung Neoplasms; Male; Middle Aged; Platinum; Pleura; Pleural Effusion, Malignant; Pleurisy; Pneumonectomy; Prognosis | 1993 |
[Pharmakinetics of carboplatin in cancer patients].
Topics: Adult; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Platinum | 1991 |
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
Topics: Adenocarcinoma; Breast Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; DNA; Drug Resistance; Glutathione Transferase; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured | 1991 |
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Topics: Antineoplastic Agents; Biological Assay; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tumor Cells, Cultured | 1991 |
The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
Topics: Carcinoma, Small Cell; Cell Line; Cisplatin; DNA; DNA, Neoplasm; Drug Resistance; Humans; Lung Neoplasms; Platinum; Tumor Cells, Cultured | 1990 |
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; Carboplatin; Carcinoma, Small Cell; Cell Line; Cisplatin; Coloring Agents; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1990 |
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.
Topics: Carcinoma, Small Cell; Cell Line; Cell Survival; Cisplatin; DNA; Docosahexaenoic Acids; Drug Resistance; Fatty Acids; Glutathione; Humans; Lung Neoplasms; Phospholipids; Platinum; Sphingolipids; Tumor Cells, Cultured | 1989 |